XML 32 R21.htm IDEA: XBRL DOCUMENT v3.25.1
STOCKHOLDERS’ EQUITY (DEFICIT) (Tables)
3 Months Ended
Sep. 30, 2024
Class of Warrant or Right [Line Items]  
SCHEDULE OF STOCK OPTIONS ACTIVITY

Activity in the Company’s stock options during the three months ended September 30, 2024 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contract Term
(# years)
   Aggregate intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding at June 30, 2024   1,605,060   $4.85             
Granted                   $ 
Exercised              $     
Forfeited and cancelled   (84,942)   3.39             
Outstanding at September 30, 2024   1,520,118    4.94    7.63         
Exercisable at September 30, 2024   420,825    8.88    4.55         

 

Activity in the Company’s stock options during the three months ended September 30, 2023 and related balances outstanding as of that date are reflected below:

 

   Number of Shares   Weighted Average Exercise Price   Weighted Average Remaining Contract Term
(# years)
   Aggregate intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding at June 30, 2023   973,400   $6.44             
Granted                  $ 
Exercised              $     
Forfeited and cancelled   (34,230)   8.19             
Outstanding at September 30, 2023   939,170    6.40    7.29         
Exercisable at September 30, 2023   376,978    10.82    4.62         
SCHEDULE OF RESTRICTED STOCK UNITS ACTIVITY

Activity in RSUs during the three months ended September 30, 2024 and related balances outstanding as of that date are reflected below:

 

  

Number of

Shares

   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contract Term (# years) 
Outstanding at June 30, 2024   114,666   $5.56      
Granted             
Vested and settled             
Forfeited and cancelled             
Outstanding at September 30, 2024   114,666    5.56    0.36 

 

 

Activity in RSUs during the three months ended September 30, 2023 and related balances outstanding as of that date are reflected below:

 

  

Number of

Shares

   Weighted Average Grant Date Fair Value   Weighted Average Remaining Contract Term (# years) 
Outstanding at June 30, 2023   193,749   $6.09      
Granted             
Vested and settled             
Forfeited and cancelled   (1,539)   5.75      
Outstanding at September 30, 2023   192,210    6.09    0.74 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSES

The following table summarizes stock-based compensation expense for employee and non-employee stock option and RSU grants:

 

   2024   2023 
  

Three months ended September 30,

 
   2024   2023 
Selling and administrative  $319,000   $216,000 
Research and development   28,000    60,000 
Total stock-based compensation expense  $347,000   $276,000 
Warrant [Member]  
Class of Warrant or Right [Line Items]  
SCHEDULE OF STOCK WARRANT ACTIVITY

Warrant detail for the three months ended September 30, 2024 is reflected below:

 

  

Number of

Warrants

   Weighted Average Exercise Price Per Warrant   Weighted Average Remaining Contract Term (# years) 
Warrants outstanding and exercisable at June 30, 2024   1,413,110   $6.14      
Warrants issued   -    -      
Warrants exercised   -    -      
Warrants forfeited and cancelled   -    -      
Warrants outstanding and exercisable at September 30, 2024   1,413,110    6.14    2.23 

 

Warrant detail for the three months ended September 30, 2023 is reflected below:

 

  

Number of

Warrants

   Weighted Average Exercise Price Per Warrant   Weighted Average Remaining Contract Term (# years) 
Warrants outstanding and exercisable at June 30, 2023   1,455,119   $6.10      
Warrants issued   -    -      
Warrants exercised   -    -      
Warrants forfeited and cancelled   (83,205)   4.00      
Warrants outstanding and exercisable at September 30, 2023   1,371,914    6.23    3.18